Deepak Nitrite Limited AI Stock Analysis
Want to see IN:DEEPAKNTR full AI Analyst Report?
Deepak Nitrite Limited (DEEPAKNTR) AI Stock Analysis
Deepak Nitrite Limited
(NSE:DEEPAKNTR)
The overall score is constrained by significant financial performance weaknesses, including sharp margin erosion and negative free cash flow. Technicals show some near-term strength, but overbought stochastic signals caution. Valuation is neutral and does not compensate for fundamental risks.
Deepak Nitrite Limited (DEEPAKNTR) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 208.85B
- Dividend Yield
- 0.49%
- Average Volume (3M)
- 41.72K
- Price to Earnings (P/E)
- 19.7
- Beta (1Y)
- 0.81
- Revenue Growth
- 25.13%
- EPS Growth
- 99.89%
- Country
- India
- Employees
- 1,720
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals
Deepak Nitrite Limited Business Overview & Revenue Model
Company Description
Incorporated in 1970 and headquartered in Vadodara, India, Deepak Nitrite Limited operates as a prominent manufacturer and seller of a diverse portfolio of chemicals. Its offerings span basic, fine, and specialty chemicals, as well as performance pro...
Deepak Nitrite Limited Financial Statement Overview
Summary
Revenue growth is offset by severe margin compression and negative free cash flow. Gross margin fell from 41.3% to 14.7%, and FCF is deeply negative, indicating poor cash conversion. Balance sheet remains moderate, but declining ROE and rising debt add risk.
Income Statement
45NeutralBalance Sheet
58NeutralCash Flow
32Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 96.31B | 77.85B | 80.91B | 76.10B | 78.83B | 67.73B |
| Gross Profit | 24.27B | 11.47B | 18.03B | 18.79B | 19.54B | 21.91B |
| EBITDA | 17.21B | 10.28B | 11.76B | 12.79B | 13.37B | 16.46B |
| Net Income | 10.62B | 5.51B | 6.97B | 8.11B | 8.52B | 10.67B |
Balance Sheet | ||||||
| Total Assets | 98.14B | 86.81B | 77.18B | 60.96B | 51.29B | 44.30B |
| Cash, Cash Equivalents and Short-Term Investments | 3.72B | 4.64B | 9.14B | 5.83B | 4.16B | 4.79B |
| Total Debt | 17.62B | 16.38B | 12.67B | 2.86B | 728.60M | 3.15B |
| Total Liabilities | 32.92B | 28.11B | 22.93B | 12.74B | 10.39B | 10.92B |
| Stockholders Equity | 64.76B | 58.37B | 53.89B | 47.97B | 40.90B | 33.38B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -6.67B | -4.83B | 1.06B | 2.89B | 6.37B |
| Operating Cash Flow | 0 | 5.17B | 6.39B | 8.78B | 6.50B | 8.24B |
| Investing Cash Flow | 0 | -6.85B | -15.25B | -7.22B | -2.76B | -4.24B |
| Financing Cash Flow | 0 | 2.32B | 8.26B | 435.30M | -3.59B | -3.86B |
Deepak Nitrite Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:DEEPAKNTR, the sentiment is Negative. The current price of 1530.15 is below the 20-day moving average (MA) of 1532.65, below the 50-day MA of 1565.04, and below the 200-day MA of 1616.19, indicating a neutral trend. The MACD of 4.72 indicates Negative momentum. The RSI at 48.91 is Neutral, neither overbought nor oversold. The STOCH value of 46.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:DEEPAKNTR.
Deepak Nitrite Limited Peers Comparison
Overall Rating
IN:GNFC71Outperform
IN:DEEPAKFERT65Neutral
IN:VALIANTORG63Neutral
IN:DEEPAKNTR52Neutral
IN:ACI49Neutral
IN:TATACHEM47Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 71Outperform | INR 68.62B | 6.50 | ― | 4.51% | 22.49% | 65.41% | |
| 65Neutral | INR 183.08B | 15.58 | ― | 0.69% | 13.94% | 18.32% | |
| 63Neutral | INR 9.50B | 13.78 | ― | ― | 21.32% | 175.87% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 52Neutral | INR 211.97B | 19.66 | ― | 0.49% | 25.13% | 99.89% | |
| 49Neutral | INR 53.93B | 53.23 | ― | 0.58% | 5.99% | -41.58% | |
| 47Neutral | INR 165.54B | -6.89 | ― | 1.72% | 4.93% | -1174.55% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:DEEPAKNTR | Deepak Nitrite Limited | 1530.15 | -87.71 | -5.42% | |
| IN:ACI | Archean Chemical Industries Ltd. | 432.45 | -102.43 | -19.15% | |
| IN:DEEPAKFERT | Deepak Fertilisers and Petrochemicals Corporation Ltd. | 1440.50 | 87.53 | 6.47% | |
| IN:GNFC | Gujarat Narmada Valley Fertilizers & Chemicals Ltd. | 465.40 | -5.11 | -1.09% | |
| IN:TATACHEM | Tata Chemicals Limited | 639.15 | -153.03 | -19.32% | |
| IN:VALIANTORG | Valiant Organics Limited | 321.85 | 64.80 | 25.21% |
Deepak Nitrite Limited Corporate Events
Deepak Nitrite schedules Q2 and H1 FY27 earnings call for October 30
Deepak Nitrite Limited has announced that it will host an earnings conference call to discuss its financial results for the second quarter and half year of FY27, ended 30 September 2026. The call, scheduled for Friday, 30 October 2026 at 3:30 PM IST...
Deepak Nitrite Discloses Resignation of Life Sciences SBU Head
Deepak Nitrite Limited has announced a managerial change in its life sciences strategic business unit, with the resignation of Mr. Puneet Sharma as SBU Head – Life Sciences. His resignation is effective from the close of business on 21 August 2026, a...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 17, 2026
